OMI heads north again
Thursday, 31 July, 2008
Occupational and Medical Innovations [ASX: OMI] has found a Canadian distribution partner for its auto-retractable safety syringes.
OMI has granted Domrex Pharma exclusive rights to distribute the syringes in Canada, but OMI's pre-existing deal granting Cardinal Health distribution rights in Canada will still be honoured.
The deal will last three years, and will be extended if minimum sales targets are met.
The safety syringes have yet to be approved for sale in Canada, but OMI expects to obtain regulatory approvals in late August or early September.
OMI announced yesterday that the Federal Court of Australia had found that its syringe device did not infringe the patent of US competitor Retractable Technologies (RTI).
RTI is also suing Becton Dickinson (BD) in the US for patent infringement.
Heart muscle regeneration genes mapped
Researchers have uncovered insights into how stem cells develop and mature into heart muscle...
The cause of 2022's mpox outbreak revealed
Researchers have discovered that the strain of mpox behind the 2022 outbreak was a weakened form...
New gene therapy treats liver disorder in growing children
Researchers have developed a genome-editing approach that repairs a faulty gene directly at its...
